{"title":"Pharmaceutical Manufacturing with Additive Technology: A Key Driver of Industry 4.0 Integration.","authors":"Manjoo Rani","doi":"10.2174/0126673878339327250227021950","DOIUrl":"https://doi.org/10.2174/0126673878339327250227021950","url":null,"abstract":"<p><p>Additive Manufacturing (AM) has emerged as a transformative force in the pharmaceutical industry, establishing itself as a cornerstone of Industry 4.0. This review explores the capability of 3D printing (3DP) technologies that facilitate the creation of individualized dosage forms, precise drug release control, and customized drug delivery systems. These innovations have significantly improved treatment outcomes and efficiency. The study identifies key challenges hindering the widespread adoption of AM in pharmaceuticals, including issues related to material selection, regulatory compliance, and process efficiency. By analyzing the interrelationship between AM and the fundamental pillars of Industry 4.0, we demonstrate how AM can optimize manufacturing costs, reduce production time, and minimize waste. The review also presents a strategic roadmap for future research, emphasizing the need for interdisciplinary collaboration to overcome regulatory barriers, develop medical-grade materials, and optimize manufacturing processes through advanced computational models and machine learning. This approach aims to accelerate the integration of AM into pharmaceutical manufacturing, ultimately enhancing personalized patient care and therapeutic effectiveness.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fabrication and Efficacy Assessment of a Combination of Polyherbal Facewash Gels for the Treatment of Propionibacterium acnes.","authors":"Suman Shrivastava, Saurabh Shrivastava, Rakesh Tirkey","doi":"10.2174/0126673878340038250224063731","DOIUrl":"https://doi.org/10.2174/0126673878340038250224063731","url":null,"abstract":"<p><strong>Introduction: </strong>Azadirachta indica is also referred to as margosa or neem. It is found throughout the Indian subcontinent. Aegle marmelos L. (family: Rutaceae), sometimes referred to as Bael in Hindi, is a crucial food plant in India. The fruit has traditionally been used for the treatment of inflammation, diabetes, respiratory disorders, diarrhea, and dysentery. Aegle marmelos fruits are abundant in coumarins, carotenoids, terpenoids, and flavonoids. The plant referred to as Camellia sinensis, or tea, is part of the Theaceae family and is often grown in tropical and subtropical regions.</p><p><strong>Objective: </strong>Acne is a prolonged inflammatory condition of the skin that has a significant negative influence on patients' quality of life all over the world. Although it is most commonly seen in young people, it may impact people of any age. Herbal anti-acne facewash gels were prepared using Carbopol 934 and extracts from Azadirachta indica, Aegle marmelos L., and Camellia sinensis.</p><p><strong>Materials and methods: </strong>The anti-acne facewash gel formulations were prepared in five different concentrations of 1%, 0.90%, 0.80%, 0.60%, and 0.50%, labeled as F1, F2, F3, F4, and F5, respectively.</p><p><strong>Results: </strong>The anti-acne properties of the formulations were evaluated. The outcomes demonstrated gels to have an excellent spreading coefficient, a great physical appearance, and be non-irritating. Standard commercial formulations were used to investigate the effectiveness.</p><p><strong>Conclusion: </strong>Unlike marketed formulations, the developed formulation 3 (F3) demonstrated an excellent spreading coefficient and good % extrudability. It has been shown to be a more potent and effective polyherbal anti-acne facewash gel for treating acne. In recent years, there has been a rise in the patenting of herbal formulations, and several in vitro and in vivo studies have produced scientific proof of their medicinal efficacy. This work discusses many patented herbal compositions and how they might be used therapeutically to treat different diseases.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amit Kumar Singh, Prabhat Kumar Upadhyay, Manish Kumar
{"title":"Formulation Development and Permeation Studies of Vancomycin Hydrochloride-Loaded Nanostructured Lipid Carrier Incorporated Thermoresponsive In-Situ Gel: A Box-Behnken Design Implemented Approach for Ocular Delivery in Endophthalmitis.","authors":"Amit Kumar Singh, Prabhat Kumar Upadhyay, Manish Kumar","doi":"10.2174/0126673878339109250219072409","DOIUrl":"https://doi.org/10.2174/0126673878339109250219072409","url":null,"abstract":"<p><strong>Background: </strong>Endophthalmitis, an inflammatory condition of the intraocular cavity, poses a significant challenge in ophthalmology due to its rapid progression and potential for vision loss. Conventional treatment modalities, such as systemic antibiotics or oral administration, often face limitations in achieving the required therapeutic levels at the target site. Hence, repeated intravitreal injections of antibiotics are currently the most preferred and recommended therapy for the management of endophthalmitis, which is an invasive technique and has certain shortcomings, elevated intraocular pressure, bleeding inside the eye, heightened likelihood of retinal detachment, retinal toxicity, and many more. Vancomycin is the first choice drug for the management of endophthalmitis and is given through intravitreal injection.</p><p><strong>Aim: </strong>The work aims to design, develop, and evaluate Vancomycin-loaded NLCs incorporated into an in-situ gel offering a new non-invasive therapeutic option for the management of Endophthalmitis.</p><p><strong>Method: </strong>The Vancomycin-loaded NLCs were successfully produced through a double emulsion/ solvent evaporation method employing a Box Behnken design. The optimized formulations were incorporated into an in-situ gel system by varying the concentration of Pluronic F127. The formulated gels were characterized for several parameters such as physical appearance, pH, viscosity, gelling strength, gelation temperature, in vitro release profile, and ex-vivo permeation study.</p><p><strong>Results: </strong>The result revealed that the formulation had a smooth appearance with a pH range from 7 to 7.5, was near the physiological pH of the eye, had content in the range of 97.5 ± 1.0 %to 99.2 ± 1.0 % and gelation temperature near body temperature. The data of release study formulation (VISG2) revealed sustained drug release compared to the control gel. The data ex vivo permeation study revealed that there was approximately a 3 folds increase in permeation of drug form (VISG2) compared to control gel (p˂0.0001) and significant (2.02folds) permeation compared to commercially available formulation (p˂0.0001).</p><p><strong>Conclusion: </strong>In conclusion, the Vancomycin-loaded NLCs incorporated in-situ gel may serve as a feasible alternative to invasive intravitreal injection for the management of endophthalmitis.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143485270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Agomelatine Transdermal System Product Cycle: Development, Material/Process Screening, Optimization, Characterization, Delivery Mechanics and Irritation study on Rat.","authors":"Punitkumar Rathod, Anita Lalwani","doi":"10.2174/0126673878339412250213043818","DOIUrl":"https://doi.org/10.2174/0126673878339412250213043818","url":null,"abstract":"<p><strong>Introduction/objective: </strong>Agomelatine (AGT) is used for the treatment of major depressive disorder in adults. Agomelatine is highly susceptible to first-pass metabolism, and it has less than 5% oral bioavailability. Therapy for major depressive disorder extends for a long period and every time, additional caregivers are required to remind and manage the timely dosing of oral medicine to patients. In such cases, once a week, administration of agomelatine via transdermal patch dosage form provides major patient benefits and lowers overall therapy costs.</p><p><strong>Methods: </strong>An agomelatine transdermal patch was prepared using the solvent evaporation method using the LTE-S Werner Mathis AG coater and dryer. A patch was prepared using silicon adhesive after screening different pressure-sensitive adhesives like acrylate, polyisobutylene, and silicon. To make a crystal-free patch, the concentration of povidone k-29/32 was optimized in preliminary trials. To deliver the drug over a 7-day period, propylene glycol monolaurate (PGML) was identified from different penetration enhancers. Three factors optimization was carried out, like the concentration of povidone k-29/32, the concentration of PGML, and the mixing time of the blend using the Box Behnken design. 3D surface response curves and contour plots were derived using Design Expert and Minitab software. From overlay plots, design spaces were identified.</p><p><strong>Result: </strong>The optimized AGT patch has good adhesion properties along with a desirable flux of 4.63 μg/cm2/h on human cadaver skin along with a lower residual drug. There was no impact of heat flux studies on normal conditions, hence justifying the in-use condition of the patient population during hot showers, baths, and saunas. AGT Patch was also non-irritating in skin irritation studies performed on Wistar albino rats.</p><p><strong>Conclusion: </strong>It was concluded that agomelatine transdermal patches can be manufactured using silicon adhesive, povidone k-29/32, and propylene glycol monolaurate for the treatment of major depressive disorder and will be the most convenient and cost-effective therapy for the patient.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143451365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Green Synthesis of Chlorophyllin-Based Ag Nanoparticles to Target Escherichia coli and Staphylococcus aureus.","authors":"Sandipa Podder, Saikat Saha, Arnob Chakrovorty, Banani Bhattacharjee, Sabir Hossen Molla, Debojyoti Tarafdar, Sisir Nandi, Asmita Samadder","doi":"10.2174/0126673878360429250207063902","DOIUrl":"https://doi.org/10.2174/0126673878360429250207063902","url":null,"abstract":"<p><strong>Background: </strong>Bacteria resist drugs by employing new resistance mechanisms, leading to prolonged infection and complexity in therapeutic prognosis that concordantly decreases drug efficacy. In recent years, nanotechnology has gained immense popularity for the development of drug delivery systems to combat the global pharmaceutical crisis of multi-drug resistance.</p><p><strong>Objective: </strong>The present work aimed to focus on the green chemistry-based synthesis of silver nanoparticles (AgNPs) using the phytocompound chlorophyllin to form chlorophyllin precipitated silver nanoparticles (NCHL) and elucidate their application against two pathologically significant bacterial species Escherichia coli and Staphylococcus aureus.</p><p><strong>Methods: </strong>After optimization of experimental parameters, the physico-chemical properties of the synthesized NCHL were determined using AFM, DLS, XRD, UV-Vis, SPR, and FTIR, respectively. The interaction of NCHL with ct-DNA was assessed using CD spectroscopy. The antimicrobial activity of the synthesized NCHL against Escherichia coli and Staphylococcus aureus was examined by a disc diffusion susceptibility test.</p><p><strong>Results: </strong>The NCHL was ascertained to be ~53.57 nm in size, having a spherical shape, smooth topology, negative zeta potential of -23.94 mV, and PDI value of 0.495. A sharp peak for silver as SPR and an XRD peak depicted the best fit metallic crystal synchronization. FTIR analysis revealed the presence of a similar functional group in NCHL and chlorophyllin (CHL). CD spectroscopy with ct-DNA in the presence of NCHL showed a change in spectral shift of the ct-DNA, indicating strong ct-DNA-NCHL interaction. NCHL successfully inhibited the growth of both bacterial strains, indicating broad spectrum activity of the synthesized nanoparticles.</p><p><strong>Conclusion: </strong>The promising results indicated that NCHL could be utilized as a potential therapeutic molecule against Escherichia coli and Staphylococcus aureus infections and help in combating bacterial drug resistance, which is of high medical priority.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143451367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Natural Extract-Loaded Herbal Patches: Assessment for Biomedical Application.","authors":"Shaheen Ansari, Pragya, Shikha Srivastava, Poonam Parashar","doi":"10.2174/0126673878330303241230102355","DOIUrl":"https://doi.org/10.2174/0126673878330303241230102355","url":null,"abstract":"<p><strong>Introduction and objective: </strong>Medicinal plants like Moringa and Selaginella have gained attention for their potential in wound healing including antimicrobial and antioxidant attributes. Extracts from these plants have shown promise in accelerating wound healing processes, enhancing fibroblast cell proliferation and migration, and providing antioxidant benefits. The objective of this work was to assess the therapeutic potential of extracts loaded patches for biomedical applications.</p><p><strong>Methods: </strong>Selaginella bryopteris L. and Moringa oleifera Lam. extracts were prepared using the cold maceration method. The prepared extracts were evaluated for antibacterial activity and antioxidant potential. Additionally, patches were prepared using Polyvinyl Alcohol and Hydroxypropyl Methylcellulose as polymers and evaluated for in vitro release and cell viability and biocompatibility characteristics.</p><p><strong>Result: </strong>The extract of both plants showed good antioxidant potency against ascorbic acid. Antibacterial activity revealed that Selaginella and Moringa extracts and patches consistently outperformed P. aeruginosa, B. subtilis, and S. aureus at varying concentrations. Physiochemical evaluation of patches indicated good weight uniformity, thickness, and folding endurance, with slight moisture uptake. Drug release profiles showed significant results for all formulations. The results of cell viability for patches showed an increased cell proliferation and were nontoxic.</p><p><strong>Conclusion: </strong>The study suggests that both extract and patch show excellent antibacterial activity against Staphylococcus aureus. The characterization results showed that the patches were uniform in their drug content, weight, and thickness, and they also indicated the reproducibility of the method used. In the in vitro release study of Selaginella bryopteris L. and Moringa oleifera Lam. patches were fitted to the Higuchi model and also patches were found harmless for the cells as well as increased proliferation of cells.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143124306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ruiqi Yi, Xiaolu Yang, Ya Tian, Fen Zhang, Umer Anayyat, Xiaoting Zhang, Wang Xiaomei
{"title":"Exosomes from Different Sources in Promoting Wound Healing.","authors":"Ruiqi Yi, Xiaolu Yang, Ya Tian, Fen Zhang, Umer Anayyat, Xiaoting Zhang, Wang Xiaomei","doi":"10.2174/0126673878366772250116082511","DOIUrl":"https://doi.org/10.2174/0126673878366772250116082511","url":null,"abstract":"<p><p>Exosomes are nanoscale extracellular vesicles with various biological activities that can accelerate wound healing by regulating inflammatory responses, promoting cell proliferation and angiogenesis, and other mechanisms. Among them, plant and animal exosomes have demonstrated unique advantages due to their biological characteristics. Plant exosomes have gradually become a research hotspot due to their wide source, high biosafety, and low production cost, demonstrating significant pro-healing potential. In addition, animal exosomes, especially human-derived stem cell exosomes, have shown excellent results in promoting wound repair and have become the focus of clinical research. This review explores the mechanism of action of these exosomes and their application prospects in wound healing, providing theoretical support for future research and clinical applications.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Livia Alves Filgueiras, Francisco Thiago Bandeira Silva, Francisco das Chagas Alves Lima, Anderson Nogueira Mendes
{"title":"Scientific and Technological Prospecting on Polymeric Particles Containing Extracellular Matrix Peptides for the Treatment of Duchenne Muscular Dystrophy.","authors":"Livia Alves Filgueiras, Francisco Thiago Bandeira Silva, Francisco das Chagas Alves Lima, Anderson Nogueira Mendes","doi":"10.2174/0126673878329404250106065202","DOIUrl":"https://doi.org/10.2174/0126673878329404250106065202","url":null,"abstract":"<p><p>Duchenne muscular dystrophy is a neuromuscular disease with an overall incidence of between 1 in 5,000 newborn males. Carriers may manifest progressive muscle weakness, resulting from the progressive degeneration of skeletal muscles, generating cardiac and respiratory disorders. Considering the lack of effective treatments, different therapeutic approaches have been developed, such as protein synthesis and extracellular matrix derivatives that can be used to improve muscle regeneration, maintenance, or repair. At the same time, the use of other anti-inflammatory drugs or biological agents to replace corticosteroids conjugated to these extracellular matrix derivatives may act more effectively in controlling the progression of Duchenne muscular dystrophy. Extracellular matrix-derived peptides (eg laminin-111 derivatives) and the use of essential oils with antiinflammatory activity in polymeric particles for application in the treatment of Duchenne muscular dystrophy are discussed. For this purpose, the literature of patents and scientific articles from 2012- 2024 on LM-111 peptides and Duchenne muscular dystrophy was reviewed. Many patents focus on palliative technologies that seek to prolong the progressive effects of the disease, considering the control of the inflammatory process. The technological and scientific prospecting suggests the need for continuous research on systems that can serve as a treatment for Dystrophy.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Harnessing Polyphenols and Novel Delivery Strategies for Effective Treatment of Breast Cancer.","authors":"Varneet Sandhu, Ayushi Taneja, Sonia Dhiman, Thakur Gurjeet Singh, Inderbir Singh","doi":"10.2174/0126673878329992250112190329","DOIUrl":"https://doi.org/10.2174/0126673878329992250112190329","url":null,"abstract":"<p><p>Breast cancer continues to pose a significant global health challenge, with conventional therapies frequently hindered by resistance mechanisms and undesirable side effects. This review investigates the therapeutic potential of polyphenols-naturally occurring compounds recognized for their antioxidant, anti-inflammatory, and anti-cancer properties-as alternative or complementary treatments for breast cancer. We examine the molecular pathways through which polyphenols exert their effects, including their influence on oxidative stress modulation, inflammatory responses, cellular proliferation, apoptosis, and estrogen receptor signalling. Additionally, this review addresses innovative nano-based drug delivery systems such as nanoparticles, liposomes, niosomes, and phytosomes that enhance the stability, bioavailability, and targeted delivery of polyphenols. These advanced formulations aim to overcome challenges related to polyphenol degradation, low solubility, and rapid systemic clearance, thereby enhancing their therapeutic efficacy. Through a detailed analysis, we assess the contributions of various nanocarriers in optimizing the delivery of polyphenols specifically to breast cancer cells while minimizing systemic toxicity. The evidence presented highlights the potential of polyphenols in breast cancer management, further supported by nanoformulations that improve both stability and delivery efficiency.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143049245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Suraj Kumar, Sathvik Belagodu Sridhar, Rishabha Malviya, Bhupendra G Prajapati
{"title":"Precision Oncology: Advances in Drug Delivery and Imaging.","authors":"Suraj Kumar, Sathvik Belagodu Sridhar, Rishabha Malviya, Bhupendra G Prajapati","doi":"10.2174/0126673878332787241210102302","DOIUrl":"https://doi.org/10.2174/0126673878332787241210102302","url":null,"abstract":"<p><p>The development of precise and reliable cancer treatments has been a long-standing goal in oncology. Conventional therapies often affect healthy tissues, leading to significant side effects. To overcome these challenges, researchers are exploring new methodologies that combine advanced drug delivery systems with state-of-the-art imaging technologies to target tumors more effectively. This study aims to investigate a novel approach that integrates smart drug delivery systems with real-time imaging modalities. The goal is to enhance the targeted delivery of therapeutic agents to cancer cells, minimizing damage to healthy tissues while improving the overall efficacy of cancer treatments. Smart drug delivery systems are designed to transport medications directly to tumor sites, enhancing treatment precision. When combined with real-time imaging tools such as MRI, CT, PET, and molecular imaging, these systems offer real-time data on the tumor's location, size, and response to treatment. This allows for immediate adjustments in therapy, ensuring optimal drug delivery and reducing side effects. However, the implementation of this approach also faces challenges, including the need for stringent safety protocols and adherence to regulatory standards. The integration of advanced drug delivery systems with cutting-edge imaging technologies presents a promising approach to cancer therapy. By enabling more precise treatment targeting and reducing adverse effects, this strategy has the potential to significantly improve patient outcomes in the fight against cancer.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}